SRRA

Sierra Oncology, Inc.CIK 1290149 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for SRRA PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for SRRA

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Oliger Christy J.	Director	2	$0	$0	2022-07-01
Norrett Kevin	Chief Business Officer	9	$0	$0	2022-07-01
Turner William D.	Chief Reg & Tech Ops Officer	27	$0	$830.3K	2022-07-01
Ashiya Mona	Director, 10% Owner	20	$0	$0	2022-07-01
Sinclair Andrew	Director	15	$4.05M	$0	2022-07-01
Vivo Opportunity, LLC	Director, 10% Owner	18	$0	$0	2022-07-01
Klencke Barbara	Chief Medical Officer	25	$214.1K	$0	2022-07-01
Erbez Georgia	Director	2	$0	$0	2022-07-01
Jagpal Sukhi	Chief Financial Officer	20	$0	$0	2022-07-01
Aggarwal Gaurav	Director, 10% Owner	13	$21.60M	$0	2022-07-01
DILLY STEPHEN GEORGE	CEO and President	11	$89.1K	$0	2022-07-01
Allen Andrew R	Director, 10% Owner	12	$108.2K	$0	2022-07-01
Collard Craig A	Director	7	$310.9K	$0	2022-07-01
Cooper Jeffrey H	Director	11	$0	$0	2022-07-01
Pelzer Robert	Director	12	$0	$0	2022-07-01
Thomson Mary Christina	General Counsel, CCO & Sec'y	21	$0	$249.0K	2022-07-01
ORBIMED CAPITAL LLC	Director, 10% Owner	6	$0	$0	2022-07-01
Longitude Capital Partners III, LLC	10% Owner	8	$0	$0	2022-04-27
Richardson Joshua	Director, 10% Owner	8	$4.72M	$0	2022-02-02
Tammenoms Bakker Juliet	10% Owner	1	$4.72M	$0	2022-02-02
VIVO VENTURES VII, LLC	10% Owner	1	$21.60M	$0	2022-01-31
Abingworth LLP	10% Owner	3	$4.05M	$0	2022-01-31
Kowalski Mark	Chief, Research & Early Dev	6	$0	$0	2022-01-28
ORBIMED ADVISORS LLC	Director, 10% Owner	8	$0	$0	2022-01-26
ENRIGHT PATRICK G	10% Owner	2	$0	$0	2022-01-25
Thomson Christina	General Counsel	2	$0	$0	2021-03-15
Glover Nicholas	CEO and President	4	$0	$0	2020-02-25
Longitude Venture Partners III, L.P.	10% Owner	2	$0	$0	2020-01-29
ESTES DANIEL	Director	3	$0	$0	2019-06-11
Nguyen Tran	Director	3	$0	$0	2019-06-11
Parfet Donald R	Director	8	$0	$0	2019-06-11
ONETTO NICOLE	Director	3	$0	$0	2019-06-11
Hassig Christian	Chief Scientific Officer	2	$0	$0	2019-03-04
You Angie	Chief Bus. & Strat. Officer	3	$42.9K	$0	2018-03-06
Topper James N	Director, 10% Owner	1	$8.00M	$0	2017-02-14

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Erbez Georgia	Director	D To issuer deriv	2022-07-01	2022-07-01	18,000	—	$0	0	SEC↗
Oliger Christy J.	Director	D To issuer deriv	2022-07-01	2022-07-01	18,000	—	$0	0	SEC↗
Norrett Kevin	Chief Business Officer	D To issuer deriv	2022-07-01	2022-07-01	35,000	—	$0	0	SEC↗
Norrett Kevin	Chief Business Officer	D To issuer deriv	2022-07-01	2022-07-01	11,700	—	$0	0	SEC↗
Norrett Kevin	Chief Business Officer	D To issuer deriv	2022-07-01	2022-07-01	49,000	—	$0	0	SEC↗
Norrett Kevin	Chief Business Officer	D To issuer deriv	2022-07-01	2022-07-01	100,000	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	D To issuer deriv	2022-07-01	2022-07-01	75,000	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	D To issuer deriv	2022-07-01	2022-07-01	12,300	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	D To issuer deriv	2022-07-01	2022-07-01	49,000	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	D To issuer deriv	2022-07-01	2022-07-01	35,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel	D To issuer deriv	2022-07-01	2022-07-01	35,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel	D To issuer deriv	2022-07-01	2022-07-01	12,900	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel	D To issuer deriv	2022-07-01	2022-07-01	49,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel	D To issuer deriv	2022-07-01	2022-07-01	92,000	—	$0	0	SEC↗
DILLY STEPHEN GEORGE	CEO and President	D To issuer deriv	2022-07-01	2022-07-01	92,000	—	$0	0	SEC↗
DILLY STEPHEN GEORGE	CEO and President	D To issuer deriv	2022-07-01	2022-07-01	520,000	—	$0	0	SEC↗
DILLY STEPHEN GEORGE	CEO and President	D To issuer deriv	2022-07-01	2022-07-01	260,000	—	$0	0	SEC↗
DILLY STEPHEN GEORGE	CEO and President	D To issuer deriv	2022-07-01	2022-07-01	165,000	—	$0	0	SEC↗
Collard Craig A	Director	D To issuer deriv	2022-07-01	2022-07-01	10,000	—	$0	0	SEC↗
Collard Craig A	Director	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Allen Andrew R	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	12,030	—	$0	0	SEC↗
Allen Andrew R	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	750	—	$0	0	SEC↗
Allen Andrew R	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	1,250	—	$0	0	SEC↗
Allen Andrew R	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	625	—	$0	0	SEC↗
Allen Andrew R	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Cooper Jeffrey H	Director	D To issuer deriv	2022-07-01	2022-07-01	1,941	—	$0	0	SEC↗
Cooper Jeffrey H	Director	D To issuer deriv	2022-07-01	2022-07-01	625	—	$0	0	SEC↗
Cooper Jeffrey H	Director	D To issuer deriv	2022-07-01	2022-07-01	625	—	$0	0	SEC↗
Cooper Jeffrey H	Director	D To issuer deriv	2022-07-01	2022-07-01	750	—	$0	0	SEC↗
Cooper Jeffrey H	Director	D To issuer deriv	2022-07-01	2022-07-01	18,061	—	$0	0	SEC↗
Cooper Jeffrey H	Director	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	625	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	671	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	970	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	16,686	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	750	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	625	—	$0	0	SEC↗
Pelzer Robert	Director	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	49,000	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	94,113	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	5,000	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	4,509	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	1,750	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	1,218	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	3,859	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	5,887	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	30,000	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	50,000	—	$0	0	SEC↗
Jagpal Sukhi	Chief Financial Officer	D To issuer deriv	2022-07-01	2022-07-01	4,200	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	30,000	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	49,000	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	167,091	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	4,999	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	4,508	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	1,749	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	11,399	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	2,061	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	11,744	—	$0	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer deriv	2022-07-01	2022-07-01	50,000	—	$0	0	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2022-07-01	2022-07-01	1,500	—	$0	0	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2022-07-01	2022-07-01	6,874	—	$0	0	SEC↗
Sinclair Andrew	Director	D To issuer deriv	2022-07-01	2022-07-01	871,125	$45.98	$40.05M	0	SEC↗
Aggarwal Gaurav	Director	D To issuer deriv	2022-07-01	2022-07-01	1,500	—	$0	0	SEC↗
Aggarwal Gaurav	Director	D To issuer deriv	2022-07-01	2022-07-01	1,455,384	—	$0	0	SEC↗
Aggarwal Gaurav	Director	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Aggarwal Gaurav	Director	D To issuer deriv	2022-07-01	2022-07-01	6,874	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	170,437	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	1,136,250	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	6,000	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	6,874	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	1,500	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	170,437	—	$0	0	SEC↗
ORBIMED CAPITAL LLC	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	1,136,250	—	$0	0	SEC↗
ORBIMED CAPITAL LLC	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	170,437	—	$0	0	SEC↗
ORBIMED CAPITAL LLC	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	170,437	—	$0	0	SEC↗
Vivo Opportunity, LLC	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	75,749	—	$0	0	SEC↗
Vivo Opportunity, LLC	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	324,740	—	$0	0	SEC↗
Vivo Opportunity, LLC	Director, 10% Owner	D To issuer deriv	2022-07-01	2022-07-01	1,455,384	—	$0	0	SEC↗
DILLY STEPHEN GEORGE	CEO and President	D To issuer	2022-07-01	2022-07-01	5,000	$55.00	$275.0K	0	SEC↗
Collard Craig A	Director	D To issuer	2022-07-01	2022-07-01	13,500	$55.00	$742.5K	0	SEC↗
Allen Andrew R	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	1,650	$55.00	$90.8K	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer	2022-07-01	2022-07-01	5,000	$55.00	$275.0K	0	SEC↗
Klencke Barbara	Chief Medical Officer	D To issuer	2022-07-01	2022-07-01	10,000	$55.00	$550.0K	0	SEC↗
Sinclair Andrew	Director	D To issuer	2022-07-01	2022-07-01	1,314,127	$55.00	$72.28M	0	SEC↗
Aggarwal Gaurav	Director	D To issuer	2022-07-01	2022-07-01	2,735,853	$55.00	$150.47M	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	226,704	$55.00	$12.47M	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	1,511,362	$55.00	$83.12M	0	SEC↗
Ashiya Mona	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	226,704	$55.00	$12.47M	0	SEC↗
ORBIMED CAPITAL LLC	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	226,704	$55.00	$12.47M	0	SEC↗
ORBIMED CAPITAL LLC	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	226,704	$55.00	$12.47M	0	SEC↗
ORBIMED CAPITAL LLC	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	1,511,362	$55.00	$83.12M	0	SEC↗
Vivo Opportunity, LLC	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	2,735,853	$55.00	$150.47M	0	SEC↗
Vivo Opportunity, LLC	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	431,947	$55.00	$23.76M	0	SEC↗
Vivo Opportunity, LLC	Director, 10% Owner	D To issuer	2022-07-01	2022-07-01	161,712	$55.00	$8.89M	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	A Award deriv	2022-06-17	2022-06-17	12,250	—	$0	12,250	SEC↗
DILLY STEPHEN GEORGE	CEO and President	A Award deriv	2022-06-17	2022-06-17	65,000	—	$0	65,000	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2022-06-17	2022-06-17	12,250	—	$0	12,250	SEC↗
Klencke Barbara	Chief Medical Officer	A Award deriv	2022-06-17	2022-06-17	12,250	—	$0	12,250	SEC↗
Norrett Kevin	Chief Business Officer	A Award deriv	2022-06-17	2022-06-17	12,250	—	$0	12,250	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	A Award deriv	2022-06-17	2022-06-17	12,250	—	$0	12,250	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	1,964,771	—	$0	0	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	588	—	$0	5,611	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	840	—	$0	8,015	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	252	—	$0	2,404	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	175,000	—	$0	0	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	7,175	—	$0	7,175	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	5,023	—	$0	5,023	SEC↗
Longitude Capital Partners III	10% Owner	J Other	2022-04-27	2022-04-29	2,152	—	$0	2,152	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise deriv	2022-04-06	2022-04-07	6,347	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise	2022-04-06	2022-04-07	6,347	$12.05	$76.5K	6,347	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	S Sale	2022-04-06	2022-04-07	6,347	$37.25	$236.4K	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise deriv	2022-04-05	2022-04-07	100	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	S Sale	2022-04-05	2022-04-07	100	$37.09	$3.7K	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise	2022-04-05	2022-04-07	100	$12.05	$1.2K	100	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	M Exercise deriv	2022-04-04	2022-04-04	2,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	S Sale	2022-04-04	2022-04-04	2,000	$35.14	$70.3K	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	M Exercise	2022-04-04	2022-04-04	2,000	$13.04	$26.1K	2,000	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise deriv	2022-03-18	2022-03-22	100	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	S Sale	2022-03-18	2022-03-22	100	$37.05	$3.7K	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise	2022-03-18	2022-03-22	100	$12.05	$1.2K	100	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise deriv	2022-03-17	2022-03-17	3,453	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise	2022-03-17	2022-03-17	3,453	$12.05	$41.6K	3,453	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	S Sale	2022-03-17	2022-03-17	3,453	$37.06	$128.0K	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	A Award deriv	2022-03-14	2022-03-14	35,000	—	$0	35,000	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	A Award deriv	2022-03-14	2022-03-14	35,000	—	$0	35,000	SEC↗
Norrett Kevin	Chief Business Officer	A Award deriv	2022-03-14	2022-03-14	35,000	—	$0	35,000	SEC↗
Klencke Barbara	Chief Medical Officer	A Award deriv	2022-03-14	2022-03-14	50,000	—	$0	50,000	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2022-03-14	2022-03-14	50,000	—	$0	50,000	SEC↗
DILLY STEPHEN GEORGE	CEO and President	A Award deriv	2022-03-14	2022-03-14	165,000	—	$0	165,000	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	M Exercise deriv	2022-03-04	2022-03-04	2,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	S Sale	2022-03-04	2022-03-04	2,000	$30.60	$61.2K	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	M Exercise	2022-03-04	2022-03-04	2,000	$13.04	$26.1K	2,000	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise deriv	2022-02-07	2022-02-08	10,000	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	S Sale	2022-02-07	2022-02-08	10,000	$32.32	$323.2K	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise	2022-02-07	2022-02-08	10,000	$12.05	$120.5K	10,000	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	M Exercise deriv	2022-02-04	2022-02-04	2,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	M Exercise	2022-02-04	2022-02-04	2,000	$13.04	$26.1K	2,000	SEC↗
Thomson Mary Christina	General Counsel, CCO & Sec'y	S Sale	2022-02-04	2022-02-04	2,000	$29.78	$59.6K	0	SEC↗
Richardson Joshua	Director, 10% Owner	P Buy	2022-02-02	2022-02-02	175,000	$27.00	$4.72M	175,000	SEC↗
Tammenoms Bakker Juliet	10% Owner	P Buy	2022-02-02	2022-02-02	175,000	$27.00	$4.72M	175,000	SEC↗
Aggarwal Gaurav	Director, 10% Owner	P Buy	2022-01-31	2022-01-31	800,000	$27.00	$21.60M	2,735,853	SEC↗
VIVO VENTURES VII, LLC	10% Owner	P Buy	2022-01-31	2022-01-31	800,000	$27.00	$21.60M	2,735,853	SEC↗
Abingworth LLP	10% Owner	P Buy	2022-01-31	2022-02-01	150,000	$27.00	$4.05M	1,314,127	SEC↗
Sinclair Andrew	Director	P Buy	2022-01-31	2022-02-01	150,000	$27.00	$4.05M	1,314,127	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	A Award deriv	2022-01-28	2022-01-28	12,250	—	$0	12,250	SEC↗
Thomson Mary Christina	General Counsel & Secretary	A Award deriv	2022-01-28	2022-01-28	12,250	—	$0	12,250	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2022-01-28	2022-01-28	12,250	—	$0	12,250	SEC↗
DILLY STEPHEN GEORGE	CEO and President	A Award deriv	2022-01-28	2022-01-28	65,000	—	$0	65,000	SEC↗
Norrett Kevin	Chief Business Officer	A Award deriv	2022-01-28	2022-01-28	12,250	—	$0	12,250	SEC↗
Kowalski Mark	Chief, Research & Early Dev	A Award deriv	2022-01-28	2022-01-28	12,250	—	$0	12,250	SEC↗
Klencke Barbara	Chief Medical Officer	A Award deriv	2022-01-28	2022-01-28	12,250	—	$0	12,250	SEC↗
Abingworth LLP	10% Owner	X Exercise deriv	2022-01-28	2022-02-01	287,471	—	$0	0	SEC↗
Sinclair Andrew	Director	X Exercise deriv	2022-01-28	2022-02-01	287,471	—	$0	0	SEC↗
Abingworth LLP	10% Owner	X Exercise	2022-01-28	2022-02-01	287,471	$13.20	$3.79M	1,164,127	SEC↗
Sinclair Andrew	Director	X Exercise	2022-01-28	2022-02-01	287,471	$13.20	$3.79M	1,164,127	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise deriv	2022-01-26	2022-01-28	5,000	—	$0	0	SEC↗
Thomson Mary Christina	General Counsel & Secretary	M Exercise deriv	2022-01-26	2022-01-28	2,000	—	$0	0	SEC↗
Aggarwal Gaurav	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	1,455,384	$13.20	$19.21M	0	SEC↗
Vivo Opportunity, LLC	10% Owner	X Exercise deriv	2022-01-26	2022-01-28	1,455,384	$13.20	$19.21M	0	SEC↗
Vivo Opportunity, LLC	10% Owner	X Exercise deriv	2022-01-26	2022-01-28	324,740	$13.20	$4.29M	0	SEC↗
Vivo Opportunity, LLC	10% Owner	X Exercise deriv	2022-01-26	2022-01-28	75,749	$13.20	$999.9K	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	56,244	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	374,962	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	56,244	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	56,244	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	56,244	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	X Exercise deriv	2022-01-26	2022-01-28	374,962	—	$0	0	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	M Exercise	2022-01-26	2022-01-28	5,000	$12.05	$60.3K	5,000	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	S Sale	2022-01-26	2022-01-28	5,000	$27.05	$135.3K	0	SEC↗
Thomson Mary Christina	General Counsel & Secretary	M Exercise	2022-01-26	2022-01-28	2,000	$13.04	$26.1K	2,000	SEC↗
Thomson Mary Christina	General Counsel & Secretary	S Sale	2022-01-26	2022-01-28	2,000	$29.00	$58.0K	0	SEC↗
Aggarwal Gaurav	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	480,277	$13.20	$6.34M	1,935,853	SEC↗
Vivo Opportunity, LLC	10% Owner	X Exercise	2022-01-26	2022-01-28	107,164	$13.20	$1.41M	431,947	SEC↗
Vivo Opportunity, LLC	10% Owner	X Exercise	2022-01-26	2022-01-28	24,996	$13.20	$329.9K	161,712	SEC↗
Vivo Opportunity, LLC	10% Owner	X Exercise	2022-01-26	2022-01-28	480,277	$13.20	$6.34M	1,935,853	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	56,244	$13.20	$742.4K	226,704	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	374,962	$13.20	$4.95M	1,511,362	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	56,244	$13.20	$742.4K	226,704	SEC↗
Ashiya Mona	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	374,962	$13.20	$4.95M	1,511,362	SEC↗
Ashiya Mona	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	56,244	$13.20	$742.4K	226,704	SEC↗
Ashiya Mona	Director, 10% Owner	X Exercise	2022-01-26	2022-01-28	56,244	$13.20	$742.4K	226,704	SEC↗
Richardson Joshua	Director, 10% Owner	X Exercise deriv	2022-01-25	2022-01-27	1,477,125	$13.20	$19.50M	0	SEC↗
ENRIGHT PATRICK G	10% Owner	X Exercise deriv	2022-01-25	2022-01-27	1,477,125	$13.20	$19.50M	0	SEC↗
Richardson Joshua	Director, 10% Owner	X Exercise	2022-01-25	2022-01-27	487,451	$13.20	$6.43M	1,964,771	SEC↗
ENRIGHT PATRICK G	10% Owner	X Exercise	2022-01-25	2022-01-27	487,451	$13.20	$6.43M	1,964,771	SEC↗
Collard Craig A	Director	P Buy	2021-11-24	2021-11-24	7,899	$23.09	$182.4K	13,500	SEC↗
Collard Craig A	Director	P Buy	2021-11-23	2021-11-24	5,601	$22.95	$128.5K	5,601	SEC↗
Richardson Joshua	Director, 10% Owner	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Sinclair Andrew	Director	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Aggarwal Gaurav	Director, 10% Owner	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Allen Andrew R	Director	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Ashiya Mona	Director, 10% Owner	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Pelzer Robert	Director	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Collard Craig A	Director	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Cooper Jeffrey H	Director	A Award deriv	2021-06-08	2021-06-09	6,000	—	$0	6,000	SEC↗
Erbez Georgia	Director	A Award deriv	2021-06-02	2021-06-04	18,000	—	$0	18,000	SEC↗
Oliger Christy J.	Director	A Award deriv	2021-06-02	2021-06-04	18,000	—	$0	18,000	SEC↗
DILLY STEPHEN GEORGE	CEO and President	P Buy	2021-05-19	2021-05-20	5,000	$17.83	$89.1K	5,000	SEC↗
Thomson Mary Christina	General Counsel	A Award deriv	2021-03-15	2021-06-28	12,900	—	$0	12,900	SEC↗
DILLY STEPHEN GEORGE	CEO and President	A Award deriv	2021-03-15	2021-03-17	92,000	—	$0	92,000	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2021-03-15	2021-03-17	30,000	—	$0	30,000	SEC↗
Klencke Barbara	Chief Development Officer	A Award deriv	2021-03-15	2021-03-17	30,000	—	$0	30,000	SEC↗
Kowalski Mark	Chief Medical Officer	A Award deriv	2021-03-15	2021-03-17	30,000	—	$0	30,000	SEC↗
Norrett Kevin	Chief Business Officer	A Award deriv	2021-03-15	2021-03-17	11,700	—	$0	11,700	SEC↗
Thomson Christina	General Counsel	A Award deriv	2021-03-15	2021-03-17	12,900	—	$0	12,900	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	A Award deriv	2021-03-15	2021-03-17	12,300	—	$0	12,300	SEC↗
Klencke Barbara	Chief Development Officer	P Buy	2020-08-18	2020-08-18	3,325	$12.25	$40.7K	5,000	SEC↗
Klencke Barbara	Chief Development Officer	P Buy	2020-08-18	2020-08-18	5,950	$12.22	$72.7K	10,000	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2020-08-12	2020-08-12	5,887	—	$0	5,887	SEC↗
Kowalski Mark	Chief Medical Officer	A Award deriv	2020-08-12	2020-08-12	24,970	—	$0	24,970	SEC↗
Norrett Kevin	Chief Business Officer	A Award deriv	2020-08-10	2020-08-11	100,000	—	$0	100,000	SEC↗
Turner William D.	Chief Reg & Tech Ops Officer	A Award deriv	2020-08-04	2020-08-06	100,000	—	$0	100,000	SEC↗
Thomson Mary Christina	General Counsel	A Award deriv	2020-07-28	2021-06-28	100,000	—	$0	100,000	SEC↗
Thomson Christina	General Counsel	A Award deriv	2020-07-28	2020-07-29	100,000	—	$0	100,000	SEC↗
Sinclair Andrew	Director	A Award deriv	2020-06-09	2020-06-10	6,874	—	$0	6,874	SEC↗
Aggarwal Gaurav	Director, 10% Owner	A Award deriv	2020-06-09	2020-06-10	6,874	—	$0	6,874	SEC↗
Allen Andrew R	Director	A Award deriv	2020-06-09	2020-06-10	12,030	—	$0	12,030	SEC↗
Ashiya Mona	Director, 10% Owner	A Award deriv	2020-06-09	2020-06-10	6,874	—	$0	6,874	SEC↗
Cooper Jeffrey H	Director	A Award deriv	2020-06-09	2020-06-10	18,061	—	$0	18,061	SEC↗
Pelzer Robert	Director	A Award deriv	2020-06-09	2020-06-10	16,686	—	$0	16,686	SEC↗
Richardson Joshua	Director, 10% Owner	A Award deriv	2020-06-09	2020-06-10	6,874	—	$0	6,874	SEC↗
DILLY STEPHEN GEORGE	CEO and President	A Award deriv	2020-06-01	2020-06-02	520,000	—	$0	520,000	SEC↗
Collard Craig A	Director	A Award deriv	2020-05-28	2020-05-29	10,000	—	$0	10,000	SEC↗
Glover Nicholas	CEO and President	A Award deriv	2020-02-25	2020-02-27	359,158	—	$0	359,158	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2020-02-25	2020-02-27	94,113	—	$0	94,113	SEC↗
Klencke Barbara	Chief Development Officer	A Award deriv	2020-02-25	2020-02-27	167,091	—	$0	167,091	SEC↗
Kowalski Mark	Chief Medical Officer	A Award deriv	2020-02-25	2020-02-27	75,030	—	$0	75,030	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion deriv	2020-01-29	2020-01-31	19,500	—	$0	0	SEC↗
Aggarwal Gaurav	Director, 10% Owner	C Conversion deriv	2020-01-29	2020-01-31	19,213	—	$0	0	SEC↗
Ashiya Mona	Director, 10% Owner	C Conversion deriv	2020-01-29	2020-01-31	19,500	—	$0	0	SEC↗
Richardson Joshua	Director, 10% Owner	C Conversion deriv	2020-01-29	2020-01-31	19,500	—	$0	0	SEC↗
Longitude Venture Partners III	10% Owner	C Conversion deriv	2020-01-29	2020-01-31	19,500	—	$0	0	SEC↗
Vivo Opportunity, LLC	10% Owner	C Conversion deriv	2020-01-29	2020-01-31	1,000	—	$0	0	SEC↗
Vivo Opportunity, LLC	10% Owner	C Conversion deriv	2020-01-29	2020-01-31	4,287	—	$0	0	SEC↗
Vivo Opportunity, LLC	10% Owner	C Conversion deriv	2020-01-29	2020-01-31	19,213	—	$0	0	SEC↗
Sinclair Andrew	Director	C Conversion deriv	2020-01-29	2020-01-31	11,500	—	$0	0	SEC↗
Sinclair Andrew	Director	C Conversion deriv	2020-01-29	2020-02-03	11,500	—	$0	0	SEC↗
ORBIMED ADVISORS LLC	Director, 10% Owner	C Conversion	2020-01-29	2020-01-31	1,477,320	—	$0	1,477,320	SEC↗
Aggarwal Gaurav	Director, 10% Owner	C Conversion	2020-01-29	2020-01-31	1,455,576	—	$0	1,455,576	SEC↗
Ashiya Mona	Director, 10% Owner	C Conversion	2020-01-29	2020-01-31	1,477,320	—	$0	1,477,320	SEC↗
Richardson Joshua	Director, 10% Owner	C Conversion	2020-01-29	2020-01-31	1,477,320	—	$0	1,477,320	SEC↗
Longitude Venture Partners III	10% Owner	C Conversion	2020-01-29	2020-01-31	1,477,320	—	$0	1,477,320	SEC↗
Vivo Opportunity, LLC	10% Owner	C Conversion	2020-01-29	2020-01-31	1,455,576	—	$0	1,455,576	SEC↗
Vivo Opportunity, LLC	10% Owner	C Conversion	2020-01-29	2020-01-31	324,783	—	$0	324,783	SEC↗
Vivo Opportunity, LLC	10% Owner	C Conversion	2020-01-29	2020-01-31	75,759	—	$0	136,715	SEC↗
Sinclair Andrew	Director	C Conversion	2020-01-29	2020-01-31	871,125	—	$0	876,542	SEC↗
Sinclair Andrew	Director	C Conversion	2020-01-29	2020-02-03	871,240	—	$0	876,656	SEC↗
Aggarwal Gaurav	Director, 10% Owner	A Award deriv	2019-11-29	2019-12-03	60,000	—	$0	60,000	SEC↗
Ashiya Mona	Director, 10% Owner	A Award deriv	2019-11-29	2019-12-03	60,000	—	$0	60,000	SEC↗
Richardson Joshua	Director, 10% Owner	A Award deriv	2019-11-29	2019-12-03	60,000	—	$0	60,000	SEC↗
Sinclair Andrew	Director	A Award deriv	2019-11-29	2019-12-03	60,000	—	$0	60,000	SEC↗
Klencke Barbara	Chief Development Officer	P Buy	2019-08-23	2019-08-26	108,000	$0.44	$47.5K	162,000	SEC↗
Klencke Barbara	Chief Development Officer	P Buy	2019-08-22	2019-08-26	67,000	$0.43	$28.8K	67,000	SEC↗
Klencke Barbara	Chief Development Officer	P Buy	2019-08-22	2019-08-26	54,000	$0.45	$24.3K	54,000	SEC↗
Allen Andrew R	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Cooper Jeffrey H	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
ESTES DANIEL	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Nguyen Tran	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
ONETTO NICOLE	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Parfet Donald R	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Pelzer Robert	Director	A Award deriv	2019-06-11	2019-06-12	30,000	—	$0	30,000	SEC↗
Glover Nicholas	CEO and President	A Award deriv	2019-03-04	2019-03-05	607,500	—	$0	607,500	SEC↗
Hassig Christian	Chief Scientific Officer	A Award deriv	2019-03-04	2019-03-05	155,000	—	$0	155,000	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2019-03-04	2019-03-05	200,000	—	$0	200,000	SEC↗
Klencke Barbara	Chief Development Officer	A Award deriv	2019-03-04	2019-03-05	200,000	—	$0	200,000	SEC↗
Kowalski Mark	Chief Medical Officer	A Award deriv	2019-03-04	2019-03-05	200,000	—	$0	200,000	SEC↗
Allen Andrew R	Director	P Buy	2018-12-10	2018-12-11	66,000	$1.64	$108.2K	66,000	SEC↗
Allen Andrew R	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Cooper Jeffrey H	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Nguyen Tran	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
ONETTO NICOLE	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Parfet Donald R	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Pelzer Robert	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
ESTES DANIEL	Director	A Award deriv	2018-06-12	2018-06-14	25,000	—	$0	25,000	SEC↗
Glover Nicholas	CEO and President	A Award deriv	2018-03-06	2018-03-07	562,780	—	$0	562,780	SEC↗
Hassig Christian	Chief Scientific Officer	A Award deriv	2018-03-06	2018-03-07	205,180	—	$0	205,180	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2018-03-06	2018-03-07	180,360	—	$0	180,360	SEC↗
Klencke Barbara	Chief Development Officer	A Award deriv	2018-03-06	2018-03-07	180,360	—	$0	180,360	SEC↗
Kowalski Mark	Chief Medical Officer	A Award deriv	2018-03-06	2018-03-07	155,000	—	$0	155,000	SEC↗
You Angie	Chief Bus. & Strat. Officer	A Award deriv	2018-03-06	2018-03-07	180,360	—	$0	180,360	SEC↗
Parfet Donald R	Director	J Other	2018-01-04	2018-01-08	2,760	—	$0	0	SEC↗
Parfet Donald R	Director	J Other	2018-01-04	2018-01-08	1,068	—	$0	2,760	SEC↗
Parfet Donald R	Director	J Other	2018-01-04	2018-01-08	1,692	—	$0	1,692	SEC↗
Parfet Donald R	Director	J Other	2018-01-04	2018-01-08	3,383	—	$0	390,913	SEC↗
Parfet Donald R	Director	J Other	2018-01-04	2018-01-08	1,380	—	$0	77,235	SEC↗
Allen Andrew R	Director	A Award deriv	2017-11-10	2017-11-13	50,000	—	$0	50,000	SEC↗
Cooper Jeffrey H	Director	A Award deriv	2017-06-13	2017-06-14	25,000	—	$0	25,000	SEC↗
Nguyen Tran	Director	A Award deriv	2017-06-13	2017-06-14	25,000	—	$0	25,000	SEC↗
ONETTO NICOLE	Director	A Award deriv	2017-06-13	2017-06-14	25,000	—	$0	25,000	SEC↗
Parfet Donald R	Director	A Award deriv	2017-06-13	2017-06-14	25,000	—	$0	25,000	SEC↗
Pelzer Robert	Director	A Award deriv	2017-06-13	2017-06-14	25,000	—	$0	25,000	SEC↗
ESTES DANIEL	Director	A Award deriv	2017-05-25	2017-05-30	50,000	—	$0	50,000	SEC↗
You Angie	Chief Bus. & Strat. Officer	P Buy	2017-03-08	2017-03-09	30,000	$1.43	$42.9K	133,252	SEC↗
Glover Nicholas	CEO and President	A Award deriv	2017-03-06	2017-03-08	195,000	—	$0	195,000	SEC↗
You Angie	Chief Bus. & Strat. Officer	A Award deriv	2017-03-06	2017-03-08	70,000	—	$0	70,000	SEC↗
Jagpal Sukhi	Chief Financial Officer	A Award deriv	2017-03-06	2017-03-08	70,000	—	$0	70,000	SEC↗
Klencke Barbara	Chief Development Officer	A Award deriv	2017-03-06	2017-03-08	70,000	—	$0	70,000	SEC↗
Topper James N	Director, 10% Owner	P Buy	2017-02-14	2017-02-16	5,925,926	$1.35	$8.00M	5,925,926	SEC↗